Neil Herskowitz Biography and Net Worth

Director of Avenue Therapeutics

Mr. Herskowitz joined our Board of Directors in December 2015. Mr. Herskowitz has served as the managing member of the ReGen Group of companies, located in New York, since 1998, which include ReGen Capital Investments LLC and Riverside Claims Investments LLC. He has also served as the President of its affiliate, Riverside Claims LLC, since June 2004. He also serves as Chairman of the board of directors of Starting Point Services for Children, a not-for-profit corporation. Mr. Herskowitz received a B.B.A. in Finance from Bernard M. Baruch College in 1978.

How do I contact Neil Herskowitz?: The corporate mailing address for Mr. Herskowitz and other Avenue Therapeutics executives is 1140 Avenue of the Americas Floor 9, NEW YORK NY, 10036. Avenue Therapeutics can also be reached via phone at (781) 652-4500 and via email at [email protected]. Learn More on Neil Herskowitz's contact information.
Has Neil Herskowitz been buying or selling shares of Avenue Therapeutics?: Neil Herskowitz has not been actively trading shares of Avenue Therapeutics during the past quarter. Most recently, on Thursday, May 6th, Neil Herskowitz bought 33 shares of Avenue Therapeutics stock. The stock was acquired at an average cost of $299.25 per share, with a total value of $9,875.25. Learn More on Neil Herskowitz's trading history.
Who are Avenue Therapeutics' active insiders?: Avenue Therapeutics' insider roster includes Neil Herskowitz (Director), and Joseph Vazzano (CFO). Learn More on Avenue Therapeutics' active insiders.

Neil Herskowitz Insider Trading History at Avenue Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/6/2021	Buy	33	$299.25	$9,875.25
5/6/2021	Buy	33	$299.25	$9,875.25
2/27/2020	Buy	32	$615.00	$19,680.00
2/25/2020	Buy	133	$673.50	$89,575.50
6/18/2019	Buy	66	$439.50	$29,007.00
4/15/2019	Buy	13	$339.00	$4,407.00
3/28/2019	Buy	8	$383.25	$3,066.00
2/25/2019	Buy	66	$409.50	$27,027.00
2/5/2019	Buy	118	$441.00	$52,038.00
1/30/2019	Buy	8	$443.25	$3,546.00
1/28/2019	Buy	19	$438.00	$8,322.00
4/25/2018	Buy	13	$285.00	$3,705.00
10/17/2017	Buy	13	$375.75	$4,884.75
10/9/2017	Buy	6	$393.00	$2,358.00

Neil Herskowitz Buying and Selling Activity at Avenue Therapeutics

Avenue Therapeutics Company Overview

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.

Today's Range

Now: $0.80

$0.80

50 Day Range

MA: $0.77

$0.70

$0.93

2 Week Range

Now: $0.80

$0.17

$2.23

Volume

2,077 shs

Average Volume

123,423 shs

Market Capitalization

$2.55 million

P/E Ratio

0.04

Dividend Yield

N/A

Beta